Skip to NavigationSkip to content

Manufacturing and Production


Top Ten most popular articles on this week

Corruption and bribery feature heavily in the news this week. A recently exposed 1997 email chain shows Dr Richard Sackler, member of the billionaire founding family of Purdue Pharma, knew about the potential abuse of opioids by its clients. In India, a recent report by the Support for Advocacy and Training to Health Initiatives (Sathi) revealed the widespread use of bribes by pharmaceutical companies in India, and how they take advantage of the lax government penalties against such actions.

Partnership with payers: Communicating and negotiating with impact

NDA's Lisa Peluso, Director, Coaching and Client Engagement, outlines key strategies for interacting with audiences and payers while maximising team alignment when it comes to delivering a product to market.

Dr Richard Torbett is named as the new Chief Executive of the ABPI

Published on: 05/12/19

The Association of the British Pharmaceutical Industry (ABPI) has appointed Dr Richard Torbett as its new Chief Executive. He will assume the position on 1 January 2020.

The appointment comes after his predecessor, Mike Thompson, stepped down in June. He had served in the role since March 2016. Torbett was unanimously selected by the ABPI board after an external recruitment process with an executive search agency.

Seizures of black market diazepam tablets double in the UK in a year

The number of illegal diazepam tablets seized by the UK Border Force has doubled in a year, going from 545,000 in 2017 to 1.3 million in 2018.

Diazepam, also known as Valium, it a class-C drug that is used to treat anxiety, muscle spasms and seizures. The medicine is available on the NHS through prescription. The drug is recommended to be taken for no longer than four weeks. A person caught with the drug without a prescription could face a jail sentence of up to two years.

Patient experience: Living with desmoid fibromatosis

Published on 04/12/19 at 12:51pm

Lisa Pascoe lives with a rare, benign desmoid tumour in her abdomen. She opens up to Pharmafocus on her diagnosis and experience with the UK healthcare system, as well as her advocacy for Desmoid United UK and her proactive approach to change things for the better.

Can you explain a bit about your condition?

Purdue Pharma’s Richard Sackler ignored OxyContin addiction concerns, new emails show

A recently exposed 1997 email chain shows Dr Richard Sackler, member of the billionaire founding family of Purdue Pharma, knew about the potential abuse of opioids by its clients.

This email exchange was included in over 1,000 pages of Kentucky court records that are now being made public. They offer one of the most complete pictures to date of Sackler’s presence while working inside Purdue. From 1996 to 1999 he was Senior Vice President and was directly involved in guiding the promotional strategy for OxyContin.

AstraZeneca sells US/Canada rights for Seroquel for $41 million to "focus on main therapy areas"

AstraZeneca has announced its intention to jettison the rights to two non-core drugs in the US and Canada in order to “support the company’s focus on main therapy areas”.

The two products in question are Seroquel (quetiapine fumarate immediate release) and Seroquel XR (quetiapine fumarate extended release), atypical anti-psychotic medicines which are used in the treatment of schizophrenia and bipolar disorder.

Jeremy Corbyn writes Trump letter asking for reassurance over NHS in trade deal

Labour Party leader Jeremy Corbyn has written to US President Donald Trump demanding he confirm that he will not put up drug prices in a UK-US post-Brexit trade deal.

Reagan-era FDA Commissioner Frank Young dies

Frank Young, FDA Commissioner from 1984-1989, died on 24 November. He was 88; his son, Jonathan, said the cause was lymphoma.

Young had an impressive academic career before serving in the FDA under Presidents Ronald Reagan and George HW Bush. During the 1970s, he was responsible for key advances in the study of bacteria which made the scientific practice of cloning possible.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches